Correlation Between Apellis Pharmaceuticals and Adaptive Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Adaptive Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Adaptive Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Adaptive Biotechnologies Corp, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Adaptive Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Adaptive Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Adaptive Biotechnologies.
Diversification Opportunities for Apellis Pharmaceuticals and Adaptive Biotechnologies
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Apellis and Adaptive is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Adaptive Biotechnologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptive Biotechnologies and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Adaptive Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptive Biotechnologies has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Adaptive Biotechnologies go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Adaptive Biotechnologies
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 0.96 times more return on investment than Adaptive Biotechnologies. However, Apellis Pharmaceuticals is 1.05 times less risky than Adaptive Biotechnologies. It trades about 0.0 of its potential returns per unit of risk. Adaptive Biotechnologies Corp is currently generating about -0.01 per unit of risk. If you would invest 5,521 in Apellis Pharmaceuticals on August 27, 2024 and sell it today you would lose (2,444) from holding Apellis Pharmaceuticals or give up 44.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Adaptive Biotechnologies Corp
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Adaptive Biotechnologies |
Apellis Pharmaceuticals and Adaptive Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Adaptive Biotechnologies
The main advantage of trading using opposite Apellis Pharmaceuticals and Adaptive Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Adaptive Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will offset losses from the drop in Adaptive Biotechnologies' long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
| Adaptive Biotechnologies vs. Verve Therapeutics | Adaptive Biotechnologies vs. Beam Therapeutics | Adaptive Biotechnologies vs. Caribou Biosciences | Adaptive Biotechnologies vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |